Drug Delivery

Sorrel to Open a New Manufacturing Facility

July 07, 2020

The new site will offer initial design and development, low-volume manufacturing, and scalable high-quality production of wearable drug delivery devices.

COVID-19: Shoring Up the Drug Delivery Infrastructure

July 01, 2020

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.

Inovio to Scale-Up Manufacture of Intradermal Delivery Device for its COVID-19 Vaccine

June 24, 2020

Inovio received a $71-million contract from the US Department of Defense to scale up manufacture of its Cellectra smart device to deliver its DNA vaccine.

EC Grants Marketing Authorization for Subcutaneous Formulation of Daratumumab

June 05, 2020

The European Commission has granted marketing authorization to the Janssen Pharmaceutical Companies of Johnson & Johnson for Darzalex (daratumumab) subcutaneous formulation to treat adults with multiple myeloma.

TAE Life Sciences to Launch Drug Delivery Program After $30-Million Investment

June 04, 2020

The investment will give the company the opportunity to accelerate the development of proprietary boron-10 target drugs while it develops its neutron beam accelerator technology for Boron Neutron Capture Therapy.

Former 3M Drug Delivery Systems Launches as Kindeva Drug Delivery

May 04, 2020

Kindeva Drug Delivery plans capital investment and jobs growth.

Orgenesis to Acquire Tamir Biotechnology for Broad Spectrum Antiviral Platform

April 14, 2020

With the acquisition, Orgenesis will combine TamirBio’s ranpirnase antiviral platform with its Bioxome technology.

The Design Driver for Biosimilar Adoption

April 08, 2020

Industry opportunities are increasing for biosimilars, but companies should pay close attention to delivery device design to facilitate success.

N4 Pharma Undertakes Research Project Using a COVID-19 DNA Plasmid

April 02, 2020

N4 Pharma will be undertaking a proof-of-concept research project using a COVID-19 DNA plasmid to demonstrate the ability of its delivery system, Nuvec, to collaborative partners developing DNA or RNA vaccines.

On Point: Biologics Drive Growth in Pre-Filled Syringes

April 01, 2020

As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.